With detection limits of 0.23 pg/mL and 0.30 pg/mL, respectively, Malhotra et al. developed an EI capable of detecting two prostate cancer biomarkers, Prostate-specific antigen (PSA) and interleukin (IL) 6 [19]. Here, KLK3 is linked to prostate carcinoma.